Silvia Foti

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience.

Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment.

Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatment.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study).

Multiparametric assessment of bone health in metastatic hormone-sensitive prostate cancer patients receiving androgen deprivation + enzalutamide ± zoledronic acid (BonEnza study).

Journal: Bone

Published: January 12, 2026

Staging Laparoscopy in High-Risk Gastric Cancer: A Decade of Real-World Evidence and Therapeutic Impact from a Tertiary Referral Center.

Staging Laparoscopy in High-Risk Gastric Cancer: A Decade of Real-World Evidence and Therapeutic Impact from a Tertiary Referral Center.

Journal: Cancers

Published: November 26, 2025

Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort.

Claudin 18.2 expression in gastroesophageal adenocarcinoma: biomarker overlap and association with clinical outcomes in a European cohort.

Journal: ESMO open

Published: October 31, 2025

Prehabilitation in oncological patients undergoing major gastrointestinal surgery: rationale and design of the PROGRESS trial.

Prehabilitation in oncological patients undergoing major gastrointestinal surgery: rationale and design of the PROGRESS trial.

Journal: Contemporary clinical trials

Published: October 17, 2025

Prehabilitation in oncological patients undergoing major gastrointestinal surgery: rationale and design of the PROGRESS trial.

Prehabilitation in oncological patients undergoing major gastrointestinal surgery: rationale and design of the PROGRESS trial.

Journal: Contemporary clinical trials

Published: October 17, 2025

Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.

Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.

Journal: Targeted oncology

Published: September 18, 2025

Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study.

Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi-Center Real-World Study.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 13, 2025

Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting.

Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting.

Journal: Targeted oncology

Published: June 03, 2025

Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study.

Ivosidenib for IDH1-Mutant Intrahepatic Cholangiocarcinoma: Insights From a Multicenter Real-World Study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 22, 2025

HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions.

HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions.

Journal: Targeted oncology

Published: February 05, 2025

Showing 1-12 of 36

Last Updated: 09/26/2026